{{medical}}
{{Drugbox|
|IUPAC_name = ''N-ethyl-1-[3-(trifluoromethyl)-<br>phenyl]propan-2-amine''
| image=(±)-Fenfluramine Structural Formulae.png
| image2=Fenfluramine-3d-CPK.png
| width=225
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number=458-24-2
| ATC_prefix=A08
| ATC_suffix=AA02
| ATC_supplemental=
| PubChem=3337
| DrugBank=APRD00319
| IUPHAR_ligand = 4613
| DrugBank2_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank2 = DB00574
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 3220
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = 2DS058H2CF
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D07945
| ChEBI_Ref = {{ebicite|correct|EBI}}
| ChEBI = 5000
| ChEMBL_Ref = {{ebicite|correct|EBI}}
| ChEMBL = 87493
| C=12 | H=16 | F=3 | N=1
| molecular_weight = 231.257
| bioavailability= ?
| metabolism = [[Hepatic|Hepatic]]
| elimination_half-life= 20 hours
| excretion = [[Renal|Renal]]
| pregnancy_AU = 
| pregnancy_US = 
| pregnancy_category = 
| legal_US = Schedule IV
| legal_status = Withdrawn from market
| routes_of_administration= Oral
}}
'''氟苯丙胺'''（'''{{lang-en|Fenfluramine}}'''），又稱'''Pondimin'''，是治療[[肥胖症|肥胖症]]的[[藥物|藥物]]。於1973年在美國市場面世。它是兩種[[對映異構體|對映異構體]]－右旋氟苯丙胺、左旋氟苯丙胺的[[外消旋體|外消旋體]]混合物。它能提高[[神經遞質|神經遞質]][[血清張力素|血清張力素]]水平－一種調節情緒食慾的[[化合物|化合物]]。它能夠干擾[[突觸小泡|突觸小泡]]來釋放[[血清張力素|血清張力素]]<ref>Nestler, Eric J. "Molecular Neuropharmacology: A Foundation for Clinical Neuroscience" McGraw-Hill, 2001.</ref>，最後促使飽滿的感覺，失去了食慾。

==因心臟病而禁止使用==
1997年因為有報告指出氟苯丙胺導致[[心臟病|心臟病]]，所以在[[美國|美國]]被禁止使用。<ref name="pmid9271479">{{cite journal |author=Connolly HM, Crary JL, McGoon MD, ''et al'' |title=Valvular heart disease associated with fenfluramine-phentermine |journal=N. Engl. J. Med. |volume=337 |issue=9 |pages=581–8 |year=1997 |pmid=9271479 |doi=10.1056/NEJM199708283370901 |url=http://content.nejm.org/cgi/content/full/337/9/581 |access-date=2008-06-24 |archive-date=2010-03-17 |archive-url=https://web.archive.org/web/20100317144522/http://content.nejm.org/cgi/content/full/337/9/581 |dead-url=no }}</ref><ref name="pmid11307869">{{cite journal |author=Weissman NJ |title=Appetite suppressants and valvular heart disease |url=https://archive.org/details/sim_american-journal-of-the-medical-sciences_2001-04_321_4/page/285 |journal=Am. J. Med. Sci. |volume=321 |issue=4 |pages=285–91 |year=2001 |pmid=11307869 |doi=10.1097/00000441-200104000-00008}}</ref> 自從美國禁止使用後，世界其他地方都跟隨禁止。由於氟苯丙胺可引致嚴重的副作用如心瓣疾病，[[香港|香港]]由1998年起已撤銷含該種成份的藥物註冊。<ref>{{Cite web |url=http://www.info.gov.hk/gia/general/200801/10/P200801100238.htm |title=減肥藥被發現含有未註冊藥物 |accessdate=2008-06-24 |archive-date=2008-02-15 |archive-url=https://web.archive.org/web/20080215232203/http://www.info.gov.hk/gia/general/200801/10/P200801100238.htm |dead-url=no }}</ref>

氟苯丙胺導致[[心瓣|心瓣]]異常肥大。Roth BL曾經建議氟苯丙胺破壞心瓣的機制。<ref name="pmid17202450">{{cite journal |author=Roth BL |title=Drugs and valvular heart disease |journal=N. Engl. J. Med. |volume=356 |issue=1 |pages=6–9 |year=2007 |pmid=17202450 |doi=10.1056/NEJMp068265}}</ref>心瓣也有[[血清張力素|血清張力素]]受體，是負責調節心瓣的生長。他的報告指出氟苯丙胺及代謝產物norfenfluramine刺激了[[血清張力素|血清張力素]]受體－[[五羥色胺|五羥色胺]]。特別是norfenfluramine針對五羥色胺受體（5-HT<sub>2B</sub>）。這些受體充斥在人類心瓣中，並對心臟生長起關鍵作用。Roth認為氟苯丙胺不恰當地刺激心瓣分裂而導致損害。

==參考資料==
<div class="references-small">
<references />
</div>

==延伸閱讀==
*Welch JT, Lim DS. (2007): "The synthesis and biological activity of pentafluorosulfanyl analogs of fluoxetine, fenfluramine, and norfenfluramine." Bioorg Med Chem. 15(21):6659. PMID 17765553.

==外部链接==
* [https://web.archive.org/web/19961114083428/http://www.rxlist.com/cgi/generic/fenflur.htm RxList.com - Fenfluramine]
* [http://www.inchem.org/documents/pims/pharm/pim938.htm Inchem.org - Fenfluramine] {{Wayback|url=http://www.inchem.org/documents/pims/pharm/pim938.htm |date=20080508200715 }}



[[Category:降食欲剂|Category:降食欲剂]]
[[Category:苯丙胺类|Category:苯丙胺类]]
[[Category:撤回药物|Category:撤回药物]]
[[Category:有机氟化合物|Category:有机氟化合物]]
[[Category:血清素受体激动剂|Category:血清素受体激动剂]]